Evidence map›Paper›PMID 32732283›Full record

ArticleThe Journal of biological chemistry2020

Modification of lipid rafts by extracellular vesicles carrying HIV-1 protein Nef induces redistribution of amyloid precursor protein and Tau, causing neuronal dysfunction.

Michael Ditiatkovski, Nigora Mukhamedova, Dragana Dragoljevic, Anh Hoang, Hann Low, Tatiana Pushkarsky, Ying Fu, Irena Carmichael, Andrew F Hill, Andrew J Murphy and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Neuro-HIV-New insights into pathogenesis and emerging therapeutic targets.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2023
    Article
  15. Review
  16. Article
  17. Trained Immunity and HIV Infection.Frontiers in immunology · 2022
    Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Michael DitiatkovskiBaker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Nigora MukhamedovaBaker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Dragana DragoljevicBaker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Anh HoangBaker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Hann LowBaker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Tatiana PushkarskyDepartment of Microbiology, Immunology and Tropical Medicine, George Washington University School of Medicine and Health Sciences, Washington, D.C., USA.
Ying FuBaker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Irena CarmichaelDepartment of Micro Imaging, Monash University, Melbourne, Victoria, Australia.
Andrew F HillDepartment of Biochemistry and Genetics, Louisiana Trobe Institute for Molecular Science, Louisiana Trobe University, Bundoora, Victoria, Australia.
Andrew J MurphyBaker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
Michael BukrinskyDepartment of Microbiology, Immunology and Tropical Medicine, George Washington University School of Medicine and Health Sciences, Washington, D.C., USA.
Dmitri SviridovBaker Heart and Diabetes Institute, Melbourne, Victoria, Australia; Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia. Electronic address: Dmitri.Sviridov@Baker.edu.au.
Baker Heart and Diabetes Institute · AUGeorge Washington University · USLa Trobe University · AUMonash University · AU

Funding

SWG 2: Cure Research Scientific Working GroupP30AI117970 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI MICHAEL Ilya BUKRINSKY · 2015 to 2026
$29.6M
The Manhattan HIV Brain BankU24MH100931 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MORGELLO, SUSAN · 2013 to 2023
$14.0M
California NeuroAIDS Tissue NetworkU24MH100928 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ACHIM, CRISTIAN L, MOORE, DAVID J · 2013 to 2023
$13.9M
NATIONAL NEUROLOGICAL AIDS BANKU24MH100929 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SINGER, ELYSE J · 2013 to 2023
$12.5M
Texas NeuroAIDS Research CenterU24MH100930 · NIMH · UNIVERSITY OF TEXAS MED BR GALVESTON · PI GELMAN, BENJAMIN B. · 2013 to 2023
$12.1M
NNTC Data Coordinating CenterU24MH100925 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI FOX, HOWARD S, SHERMAN, SETH · 2013 to 2022
$9.5M
The District of Columbia Developmental Center for AIDS Research (DC D-CFAR)P30AI087714 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI GREENBERG, ALAN EDWARD · 2010 to 2014
$8.4M
Metabolic complications of HIV disease caused by Nef released from HIV-infected cellsR01HL131473 · NHLBI · GEORGE WASHINGTON UNIVERSITY · PI BUKRINSKY, MICHAEL ILYA, SVIRIDOV, DMITRI · 2016 to 2019
$1.6M
Nef and neuroAIDS: role of cholesterol metabolism impairment and inflammationR01NS102163 · NINDS · GEORGE WASHINGTON UNIVERSITY · PI BUKRINSKY, MICHAEL ILYA · 2017 to 2019
$600k
NHLBI NIH HHS R01 HL131473NIAID NIH HHS P30 AI087714NIAID NIH HHS P30 AI117970NIMH NIH HHS U24 MH100925NIMH NIH HHS U24 MH100928NIMH NIH HHS U24 MH100929NIMH NIH HHS U24 MH100930NIMH NIH HHS U24 MH100931NINDS NIH HHS R01 NS102163
6 · The paper itself

Abstract

HIV-associated neurocognitive disorders (HANDs) are a frequent outcome of HIV infection. Effective treatment of HIV infection has reduced the rate of progression and severity but not the overall prevalence of HANDs, suggesting ongoing pathological process even when viral replication is suppressed. In this study, we investigated how HIV-1 protein Nef secreted in extracellular vesicles (exNef) impairs neuronal functionality. ExNef were rapidly taken up by neural cells

Indexed as

Amyloid beta-PeptidesAmyloid beta-Protein PrecursorAnimalsATP Binding Cassette Transporter 1Cell Line, TumorCholesterolHIV-1HIV InfectionsHumansMembrane MicrodomainsMicenef Gene Products, Human Immunodeficiency VirusNeurocognitive DisordersNeuronsPeptide Fragmentstau ProteinsABCA1 protein, humanAmyloid beta-Peptidesamyloid beta-protein (1-42)Amyloid beta-Protein PrecursorAPP protein, humanATP Binding Cassette Transporter 1CholesterolMAPT protein, humannef Gene Products, Human Immunodeficiency Virusnef protein, Human immunodeficiency virus 1Peptide Fragmentstau ProteinsamyloidcholesterolHIV-associated neurocognitive disordershuman immunodeficiency virus (HIV)lipid raftneurodegenerationTau

Identifiers

PMID32732283
PMCPMC7504931
OpenAlexW3046751196

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.